EKSO Q1 2024 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4M-8.9% YoY

Gross Profit

$2M51.9% margin

Operating Income

-$3M-86.7% margin

Net Income

-$3M-91.3% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-22.5%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$405,000

Balance Sheet

Total Assets

$29M

Total Liabilities

$15M

Stockholders' Equity

$14M

Cash & Equivalents

$9M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-8.9%
Gross Profit	$2M	$2M	-2.5%
Operating Income	-$3M	-$4M	+26.8%
Net Income	-$3M	-$4M	+21.9%

Revenue Segments

Product

$3M73%

Service

$765,00020%

Subscription

$144,0004%

Product and Service, Other

$94,0003%

Geographic Segments

Americas

$2M31%

UNITED STATES

$2M31%

EMEA

$830,00011%

Asia Pacific

$597,0008%

EMEA Other

$360,0005%

FRANCE

$346,0005%

INDONESIA

$336,0004%

APAC Other

$261,0003%

GERMANY

$124,0002%

Americas Other

$32,0000%